Back to back decisions are making it clearer that the Trump administration that the United States would no longer tolerate malpractices in trade. The latest actions by the U.S. Commerce Department takes on steel exporters from China and Mexico, over subsidies. The investigation into the imports of Fabricated Structural Steel (FSS) was initiated based on a petition filed by American Institute of Steel Construction Full Member Subgroup Chicago.
Last night, the Commerce Department announced its crackdown on certain steel products that are produced in China and Mexico and then exported to the United States as fabricated structural steel (FSS). According to the department, these products received countervailable subsidies, ranging from 30.3 to 177.43 percent in the case of China, and zero to 74.01 percent in the case of Mexico. In 2018, imports of fabricated structural steel from China and Mexico were valued at an estimated $897.5 million, and $622.4 million, respectively.
Actions like these have increased under the Trump administration and by as much as 219 percent, compared to a similar period under his predecessor.


Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
FxWirePro: Daily Commodity Tracker - 21st March, 2022
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



